Evidence map›Paper›PMID 32241388›Full record

ReviewAdvances in cancer research2020

Project PLACE: Enhancing community and academic partnerships to describe and address health disparities.

Nadine J Barrett, Kearston L Ingraham, Kenisha Bethea, Pao Hwa-Lin, Maritza Chirinos, Laura J Fish, Schenita Randolph, Ping Zhang, Peter Le, Demetrius Harvey and 2 more

Abstract readReview
In one paragraph

Review in Advances in cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nadine J BarrettDuke Cancer Institute, Duke University Medical Center, Durham, NC, United States; Department of Family Medicine and Community Health, Duke School of Medicine, Durham, NC, United States; Duke Clinical and Translational Science Institute, Duke University School of Medicine, Durham, NC, United States. Electronic address: nadine.barrett@duke.edu.
Kearston L IngrahamDuke Cancer Institute, Duke University Medical Center, Durham, NC, United States.
Kenisha BetheaDuke Clinical and Translational Science Institute, Duke University School of Medicine, Durham, NC, United States.
Pao Hwa-LinChinese Christian Church, Raleigh, NC, United States; Department of Medicine, Duke University School of Medicine, Durham, NC, United States.
Maritza ChirinosEl Centro Hispano, Durham, NC, United States.
Laura J FishDuke Cancer Institute, Duke University Medical Center, Durham, NC, United States.
Schenita RandolphDuke University School of Nursing, Durham, NC, United States.
Ping ZhangChinese American Friendly Association, Raleigh, NC, United States.
Peter LeSt. Joseph's Primary Care, Raleigh, NC, United States.
Demetrius HarveyBlack Men's Health Initiative, Wilson, NC, United States; Alumni Chapter of Kappa Alpha Psi Fraternity, Inc., Smithfield, NC, United States.
Ronald L GodbeeThe River Church, Durham, NC, United States.
Steven R PatiernoDepartment of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
NCI NIH HHS P30 CA014236
6 · The paper itself

Abstract

Achieving cancer health equity is a national imperative. Cancer is the second leading cause of death in the United States and in North Carolina (NC), where the disease disproportionately impacts traditionally underrepresented race and ethnic groups, those who live in rural communities, the impoverished, and medically disenfranchised and/or health-disparate populations at high-risk for cancer. These populations have worse cancer outcomes and are less likely to be participants in clinical research and trials. It is critical for cancer centers and other academic health centers to understand the factors that contribute to poor cancer outcomes, the extent to which they impact the cancer burden, and develop effective interventions to address them. Key to this process is engaging diverse stakeholders in the development and execution of community and population health assessments, and the subsequent programs and interventions designed to address the need across the catchment area. This chapter describes the processes and lessons learned of the Duke Cancer Institute's (DCI) long standing community partnerships that led to Project PLACE (Population Level Approaches to Cancer Elimination), a National Cancer Institute (NCI)-funded community health assessment reaching 2315 respondents in 7 months, resulting in a community partnered research agenda to advance cancer equity within the DCI catchment area. We illustrate the application of a community partnered health assessment and offer examples of strategic opportunities, successes, lessons learned, and implications for practice.

Indexed as

Health Status DisparitiesAcademic Medical CentersCommunity NetworksHumansNeoplasmsCapacityCommunity engagementCommunity health assessmentHealth disparitiesHealth equityPartnerships

Identifiers

PMID32241388
PMCPMC7526666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.